“We believe our findings are a positive step forward in helping millions of people facing heart failure,” says Ahmed Mahmoud, professor of cell and regenerative biology.
A new study of brain activity could prevent the potential trauma of patients under anesthesia regaining some awareness during medical procedures.
UW researchers say the stem cell treatment is an “extremely powerful” step toward a treatment for millions of human Parkinson’s patients.
“We believe we are launching a new cancer therapy field here,” says Jamey Weichert, professor of radiology. “It’s very exciting, and the research team is incredible.”
A gene that cured a man of HIV a decade ago has been successfully added to developing monkey embryos in an effort to study more potential treatments for the disease.
Neither of the new viruses is known to infect people, but the findings reinforce the important work scientists are undertaking to study the effects of a changing environment on human and animal diseases.
UW neuroscientists led by Su-Chun Zhang found that neurons derived from stem cells can connect with native neurons and restore motor functions. But more research is needed to translate the findings from mice to people.
Researchers believe the same approach can be applied to several other respiratory pathogens, including the novel coronavirus that causes COVID-19.
The trials center around an “antibody cocktail” called REGN-COV2, which was created by the New York-based pharmaceutical company Regeneron.
The animals are useful to researchers trying to understand SARS-CoV-2 and in the evaluation of vaccines, treatments and drugs against the disease it causes.